Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Prime Medicine Inc (PRME)

Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 516,090
  • Shares Outstanding, K 120,021
  • Annual Sales, $ 0 K
  • Annual Income, $ -198,130 K
  • 60-Month Beta 1.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.51
Trade PRME with:

Options Overview Details

View History
  • Implied Volatility 88.61% ( -60.38%)
  • Historical Volatility 62.87%
  • IV Percentile 53%
  • IV Rank 16.06%
  • IV High 365.17% on 04/05/24
  • IV Low 35.71% on 12/15/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 60
  • Volume Avg (30-Day) 116
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 1,675
  • Open Int (30-Day) 2,367

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.45
  • Number of Estimates 4
  • High Estimate -0.41
  • Low Estimate -0.52
  • Prior Year -0.44
  • Growth Rate Est. (year over year) -2.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.11 +6.57%
on 04/25/24
7.06 -37.96%
on 03/28/24
-2.28 (-34.23%)
since 03/26/24
3-Month
4.11 +6.57%
on 04/25/24
9.77 -55.17%
on 02/27/24
-2.15 (-32.92%)
since 01/26/24
52-Week
4.11 +6.57%
on 04/25/24
17.20 -74.53%
on 06/07/23
-8.86 (-66.92%)
since 04/26/23

Most Recent Stories

More News
2 Magnificent Growth Stocks With Room to Run

These deeply undervalued growth stocks could be big winners for patient shareholders.

PRME : 4.40 (+2.33%)
TLRY : 1.7850 (+2.00%)
Better Growth Stock: Archer Aviation or Prime Medicine?

Which of these innovation-themed growth stocks is the better buy?

VRTX : 398.98 (+0.32%)
CRSP : 54.09 (+0.67%)
ACHR : 3.98 (unch)
PRME : 4.40 (+2.33%)
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

CRSP : 54.09 (+0.67%)
BEAM : 21.75 (+0.69%)
CRBU : 3.73 (-0.80%)
EDIT : 5.34 (+2.30%)
NTLA : 20.63 (+3.05%)
PRME : 4.40 (+2.33%)
VERV : 6.17 (-0.80%)
LLY : 734.02 (+1.26%)
REGN : 881.19 (-1.07%)
VRTX : 398.98 (+0.32%)
ARKG : 23.15 (+0.61%)
HOOD : 17.62 (+2.92%)
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years

This gene-editing company could sport a best-in-class platform.

PRME : 4.40 (+2.33%)
ARKG : 23.15 (+0.61%)
2 Cathie Wood Stocks That Could Be Hidden Gems

These two biotech stocks could deliver life-altering returns for long-term investors.

PRME : 4.40 (+2.33%)
DNA : 0.8394 (+7.93%)
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought

There are always stocks to buy if you're Ark Invest's ace stock picker.

CRWD : 302.25 (+1.42%)
PRME : 4.40 (+2.33%)
ADPT : 2.58 (-1.15%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

There are always stocks to buy if you're Ark Invest's ace stock picker.

PATH : 19.44 (+0.15%)
PRME : 4.40 (+2.33%)
ADPT : 2.58 (-1.15%)
Prime Medicine Announces Pricing of Upsized Initial Public Offering

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of its upsized initial...

PRME : 4.40 (+2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Prime Medicine Inc. is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Prime Medicine Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 5.05
2nd Resistance Point 4.82
1st Resistance Point 4.56
Last Price 4.40
1st Support Level 4.07
2nd Support Level 3.85
3rd Support Level 3.59

See More

52-Week High 17.20
Fibonacci 61.8% 12.20
Fibonacci 50% 10.66
Fibonacci 38.2% 9.11
Last Price 4.40
52-Week Low 4.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar